GO:0090024 negative regulation of neutrophil chemotaxis: Immune Resolution Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090024 describes any process that decreases the frequency, rate, or extent of neutrophil chemotaxis, the directed movement of neutrophils toward external stimuli such as infection or wounding.
• Negative regulation of neutrophil chemotaxis is essential for limiting collateral tissue damage during inflammation and for resolving immune responses.
• Rac GTPases are central molecular switches that control neutrophil polarity and directed migration, and their downregulation or inactivation reduces chemotaxis.
• Atypical chemokine receptors such as CCRL2 modulate leukocyte migration by scavenging or presenting chemokines, thereby influencing the negative regulation of neutrophil recruitment.
• Dysregulated negative regulation of neutrophil chemotaxis contributes to sepsis heterogeneity, chronic inflammatory diseases, and tumor immune microenvironment remodeling.
• CRISPR-based knockout, point-mutation, and knock-in models enable causal dissection of genes that negatively regulate neutrophil chemotaxis.
Description
Neutrophils are the most abundant polymorphonuclear leukocytes in blood and are the first responders to infection or tissue injury. Their directed migration toward chemical gradients, termed neutrophil chemotaxis, is essential for host defense but must be tightly controlled to avoid excessive tissue damage. The Gene Ontology term GO:0090024, negative regulation of neutrophil chemotaxis, captures any process that decreases the frequency, rate, or extent of this directed movement. Understanding this process is critical because failure to restrain neutrophil migration can lead to chronic inflammation, sepsis-associated organ injury, and impaired resolution of immune responses. At the molecular level, negative regulation of neutrophil chemotaxis involves a balance between activating and inhibitory signals that converge on the cytoskeletal machinery and cell polarity pathways. Rac GTPases, for example, are key regulators of neutrophil function, and their modulation can alter the efficiency of directed migration. Chemokine scavenging by atypical receptors such as CCRL2 provides an additional layer of negative control over leukocyte recruitment. These mechanisms ensure that neutrophils arrive at the right place and time without causing bystander damage. For researchers, GO:0090024 provides a structured framework to study how specific genes, signaling molecules, and environmental cues suppress neutrophil chemotaxis. This article integrates the QuickGO definition with verified PubMed literature to outline the mechanisms, key genes, disease relevance, and experimental models used to investigate negative regulation of neutrophil chemotaxis.
negative regulation of neutrophil chemotaxis At A Glance
| GO ID | GO:0090024 |
|---|---|
| GO term | negative regulation of neutrophil chemotaxis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the frequency, rate, or extent of neutrophil chemotaxis, the directed movement of neutrophils toward external stimuli such as infection or wounding. |
| Biological context | Inflammation resolution, host defense, and prevention of collateral tissue damage. |
| Key molecular players | Rac GTPases, atypical chemokine receptors (e.g., CCRL2), and cytokines such as IL-10. |
| Disease relevance | Sepsis, chronic inflammatory diseases, and tumor immune microenvironment. |
| Research methods | CRISPR knockout, live-cell imaging, chemotaxis assays, and transcriptomics. |
What Is GO:0090024?
GO:0090024, negative regulation of neutrophil chemotaxis, is a biological process defined as any process that decreases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis itself is the directed movement of a neutrophil cell in response to an external stimulus, usually an infection or wounding. Thus, this term encompasses molecular and cellular events that dampen or restrain the migratory response of neutrophils toward chemoattractants, thereby contributing to the resolution of inflammation and protection of host tissues.
Why Is negative regulation of neutrophil chemotaxis Important in Cell Biology?
Negative regulation of neutrophil chemotaxis is essential for maintaining immune homeostasis and preventing inflammatory tissue damage. In conditions such as sepsis, the molecular mechanisms controlling neutrophil migration become dysregulated, contributing to patient heterogeneity and organ injury. Understanding how this process is negatively regulated can reveal therapeutic targets for inflammatory diseases and cancer, where neutrophil infiltration influences disease progression and treatment response.
• Prevents excessive neutrophil accumulation that can damage healthy tissues during infection.
• Contributes to the resolution phase of inflammation by limiting continued neutrophil recruitment.
• Dysregulation is associated with sepsis severity and patient heterogeneity.
• Modulates the tumor immune microenvironment, affecting cancer progression.
• Involves atypical chemokine receptors such as CCRL2 that fine-tune leukocyte migration.
• Rac GTPase signaling is a central node for both positive and negative control of neutrophil motility.
• Interleukin-10 locally suppresses neutrophil chemotaxis in models of endotoxin-induced uveitis.
• Provides targets for anti-inflammatory drug development.
• Enables mechanistic studies using CRISPR-edited immune cells.
• Helps explain heterogeneity in sepsis patient responses to therapy.
What Happens During negative regulation of neutrophil chemotaxis?
Initiation of negative signals
In simple terms: The body sends 'stop' signals to neutrophils to prevent them from over-migrating.
Negative regulation of neutrophil chemotaxis begins when inhibitory signals are generated at sites of inflammation or in the surrounding microenvironment. These signals can include anti-inflammatory cytokines such as interleukin-10, which has been shown to locally suppress neutrophil chemotaxis in endotoxin-induced uveitis. Atypical chemokine receptors like CCRL2 can also sequester or present chemokines, thereby reducing the effective concentration of chemoattractants available to neutrophils. This initiation phase sets the stage for dampening the migratory response.
Modulation of cell polarity and cytoskeletal dynamics
In simple terms: The internal compass and skeleton of the neutrophil are adjusted to slow down or redirect movement.
Neutrophil chemotaxis depends on a chemotactic compass that establishes cell polarity and directs cytoskeletal rearrangements. Negative regulation of chemotaxis involves interference with these polarity pathways, often through modulation of Rac GTPase activity. Rac GTPases are key regulators of neutrophil function, and their downregulation or inhibition can impair the formation of leading-edge structures required for efficient migration. This step ensures that neutrophils cannot maintain a persistent direction of movement.
Receptor desensitization and chemokine scavenging
In simple terms: The receptors that sense chemical trails are turned off or the trails themselves are cleared away.
Negative regulation can occur through desensitization of chemokine receptors or through scavenging of chemokines by atypical receptors. CCRL2, for example, regulates leukocyte migration by modulating the availability of chemokines, thereby acting as a negative regulator of neutrophil recruitment. This mechanism reduces the strength of the chemoattractant gradient and limits the extent of neutrophil chemotaxis. Such receptor-level control is critical for preventing prolonged activation.
Integration with resolution programs
In simple terms: The stop signals are linked to the broader process of healing and inflammation shutdown.
Negative regulation of neutrophil chemotaxis is integrated with resolution programs that actively terminate inflammation. In sepsis, the complexity of molecular mechanisms controlling neutrophil migration includes both pro- and anti-migratory signals, and their imbalance contributes to disease heterogeneity. The local expression of interleukin-10 in tolerance models demonstrates how negative regulation is coupled to immune resolution. This integration ensures that neutrophil recruitment is shut down once the threat is contained.
Key Genes Involved in GO:0090024 negative regulation of neutrophil chemotaxis
The following genes and proteins have been implicated in the negative regulation of neutrophil chemotaxis based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAC1 | Rac GTPase regulating neutrophil polarity and directed migration | Target for modulating chemotaxis in inflammatory models |
| RAC2 | Hematopoietic-specific Rac GTPase controlling neutrophil function | Key node in negative regulation of neutrophil motility |
| CCRL2 | Atypical chemokine receptor modulating leukocyte migration | Regulates chemokine availability and neutrophil recruitment |
| IL10 | Anti-inflammatory cytokine suppressing neutrophil chemotaxis | Local expression correlates with tolerance in uveitis models |
| PRTN3 | Proteinase 3 involved in myeloid differentiation | Depletion attenuates leukemia and may affect neutrophil behavior |
| COL6A6 | Collagen type VI alpha 6 chain with immune regulatory roles | Potential tumor suppressor linked to immune microenvironment |
| CXCR1 | Chemokine receptor mediating neutrophil activation | Modulated in sepsis-associated neutrophil migration |
| CXCR2 | Chemokine receptor driving neutrophil recruitment | Target for negative regulation in sepsis |
| FPR1 | Formyl peptide receptor mediating chemotaxis | Involved in sensing bacterial signals |
| PIK3CG | Phosphoinositide 3-kinase gamma in chemotaxis | Part of polarity signaling network |
| PTEN | Phosphatase counteracting PI3K signaling | Contributes to negative regulation of polarity |
| CDC42 | Rho GTPase regulating cell polarity | Modulates directed migration |
| ARPC2 | Actin-related protein complex component | Cytoskeletal dynamics in chemotaxis |
| WAS | Wiskott-Aldrich syndrome protein | Links Rac signaling to actin polymerization |
| ITGAM | Integrin alpha M involved in adhesion | Affects neutrophil migration in sepsis |
| SELL | L-selectin mediating rolling adhesion | Modulated during negative regulation |
| CXCL8 | Chemokine ligand for neutrophil recruitment | Its scavenging reduces chemotaxis |
How Is negative regulation of neutrophil chemotaxis Regulated?
Negative regulation of neutrophil chemotaxis is controlled by a network of signaling pathways that include Rac GTPase cycling, chemokine receptor desensitization, and anti-inflammatory cytokine signaling. Rac GTPases act as molecular switches whose activity is tightly regulated by guanine nucleotide exchange factors and GTPase-activating proteins, and their modulation directly affects the extent of neutrophil migration. Atypical chemokine receptors such as CCRL2 regulate the availability of chemokines, thereby adjusting the strength of the chemotactic gradient. Interleukin-10 provides a local suppressive signal that limits neutrophil chemotaxis in inflammatory conditions. In sepsis, the complexity of these regulatory mechanisms and their heterogeneity across patients highlight the need for personalized approaches to modulate neutrophil migration.
negative regulation of neutrophil chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL10 | Endotoxin-induced uveitis tolerance | IL10 knockout or overexpression in mouse uveitis models |
| CCRL2 | Leukocyte migration regulation | CCRL2 knockout mice and chemotaxis assays |
| RAC2 | Neutrophil dysfunction and inflammation | Rac2 knockout or point-mutation neutrophils |
| COL6A6 | Breast cancer immune microenvironment | COL6A6 overexpression in breast cancer cell lines |
| PRTN3 | Leukemia and myeloid differentiation | PRTN3 depletion in leukemia models |
Sepsis and systemic inflammation
Sepsis is characterized by dysregulated neutrophil migration, and the molecular mechanisms controlling this process are complex and heterogeneous among patients. Negative regulation of neutrophil chemotaxis is critical to prevent excessive tissue damage, but in sepsis this regulation may be impaired or overwhelmed. Understanding these mechanisms could lead to targeted therapies that restore appropriate negative control.
Cancer and tumor immune microenvironment
Neutrophil infiltration into tumors can influence cancer progression, and genes such as COL6A6 have been implicated in immune regulation in breast cancer. Negative regulation of neutrophil chemotaxis may affect the composition of the tumor immune microenvironment and response to immunotherapy. Targeting pathways that restrain neutrophil migration could modulate anti-tumor immunity.
Ocular inflammatory diseases
In endotoxin-induced uveitis, local expression of interleukin-10 is associated with tolerance and reduced neutrophil chemotaxis. This demonstrates that negative regulation of neutrophil chemotaxis is an active process that can be harnessed to protect ocular tissues from inflammatory damage. Therapeutic strategies that enhance this negative regulation may be beneficial in uveitis and other inflammatory eye diseases.
From negative regulation of neutrophil chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance neutrophil chemotaxis? | CRISPR knockout in neutrophil-like cell lines or primary neutrophils |
| Does a specific point mutation in RAC2 alter negative regulation? | Point-mutation knock-in in hematopoietic cells |
| Does overexpression of an anti-inflammatory gene suppress chemotaxis? | Overexpression of IL10 or CCRL2 in cell models |
| How does a tagged protein localize during chemotaxis? | Tagged knock-in of chemotaxis regulators |
| Which genes are essential for negative regulation in vivo? | CRISPR library screening in mouse models |
| Can we rescue negative regulation in sepsis? | Knock-in of regulatory variants in sepsis models |
How to Study the negative regulation of neutrophil chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Speed, directionality, and persistence of neutrophil migration | Real-time assessment of negative regulation |
| Microfluidic chemotaxis assay | Response to defined chemical gradients | Quantifying chemotaxis under controlled conditions |
| RNA sequencing | Transcriptional changes in neutrophils | Identifying genes involved in negative regulation |
| Proteomics | Protein expression and modifications | Mapping signaling networks |
| CRISPR knockout screen | Loss-of-function effects on chemotaxis | Discovery of negative regulators |
| GTPase activity assay | Rac activation state | Mechanistic studies of polarity signaling |
| Flow cytometry | Surface marker expression and cell counts | Assessing neutrophil recruitment in vivo |
| ELISA | Cytokine and chemokine levels | Measuring IL-10 and chemokine gradients |
Live-cell imaging and chemotaxis assays
Live-cell imaging combined with microfluidic chemotaxis assays allows real-time visualization of neutrophil migration and the effects of negative regulators. These methods measure speed, directionality, and persistence, providing quantitative readouts of negative regulation of neutrophil chemotaxis. They are essential for validating findings from genetic screens.
Transcriptomics and proteomics
RNA sequencing and proteomics can identify genes and proteins whose expression changes during negative regulation of neutrophil chemotaxis. These approaches reveal signaling networks and potential therapeutic targets. They are particularly useful in heterogeneous conditions such as sepsis.
CRISPR-based genetic screens
CRISPR knockout and activation screens enable unbiased discovery of genes that negatively regulate neutrophil chemotaxis. Libraries targeting kinases, GTPases, and chemokine receptors can identify novel regulators. Hits can be validated in secondary assays.
Biochemical assays for GTPase activity
Rac GTPase activity can be measured using pull-down assays or FRET biosensors to assess how negative regulators affect molecular switches. These biochemical readouts complement cellular migration assays. They provide mechanistic insight into signaling pathways.
How CRISPR Can Be Used to Study GO:0090024 negative regulation of neutrophil chemotaxis
Knockout
CRISPR knockout of candidate genes such as RAC2 or CCRL2 in neutrophil-like cell lines or primary cells can test whether they are required for negative regulation of neutrophil chemotaxis. Loss-of-function models reveal whether the gene normally restrains migration. These models are foundational for causal inference.
Point Mutation
Point mutations in genes like RAC2 can mimic human variants or alter GTPase activity, allowing precise dissection of their role in negative regulation. Knock-in of specific mutations enables study of gain-of-function or loss-of-function effects. This approach is valuable for understanding disease-associated variants.
Knock-in
Knock-in of tagged versions of chemotaxis regulators (e.g., fluorescently tagged Rac) allows real-time visualization of protein dynamics during negative regulation. This provides spatial and temporal information that cannot be obtained from fixed cells. It is also useful for reporter assays.
Overexpression
Overexpression of negative regulators such as IL10 or CCRL2 can suppress neutrophil chemotaxis and validate their inhibitory function. This approach can be used to test therapeutic potential. It complements knockout studies by providing gain-of-function evidence.
How EDITGENE Supports negative regulation of neutrophil chemotaxis Research
Researchers studying negative regulation of neutrophil chemotaxis-related genes often need to determine whether a candidate gene is causally involved in restraining neutrophil migration. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of neutrophil chemotaxis research.
Frequently Asked Questions About negative regulation of neutrophil chemotaxis
What is negative regulation of neutrophil chemotaxis?
It is any process that decreases the frequency, rate, or extent of neutrophil chemotaxis, the directed movement of neutrophils toward external stimuli such as infection or wounding.
What genes are involved in negative regulation of neutrophil chemotaxis?
Genes such as RAC2, CCRL2, IL10, and others encoding chemokine receptors and signaling molecules have been implicated.
How is negative regulation of neutrophil chemotaxis studied?
Researchers use live-cell imaging, chemotaxis assays, CRISPR screens, and transcriptomics to study this process.
Why is negative regulation of neutrophil chemotaxis important in sepsis?
In sepsis, dysregulated neutrophil migration contributes to organ injury, and understanding negative regulation may reveal therapeutic targets.
What role do Rac GTPases play in negative regulation of neutrophil chemotaxis?
Rac GTPases control cell polarity and directed migration, and their modulation can reduce chemotaxis.
How does CCRL2 regulate neutrophil chemotaxis?
CCRL2 is an atypical chemokine receptor that modulates leukocyte migration by scavenging or presenting chemokines.
Can CRISPR be used to study negative regulation of neutrophil chemotaxis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes involved.
What diseases are associated with defective negative regulation of neutrophil chemotaxis?
Sepsis, chronic inflammatory diseases, and cancer have been linked to altered neutrophil migration.
What is the GO ID for negative regulation of neutrophil chemotaxis?
The GO ID is GO:0090024.
How does interleukin-10 affect neutrophil chemotaxis?
Interleukin-10 locally suppresses neutrophil chemotaxis, as shown in models of endotoxin-induced uveitis.
Conclusion
GO:0090024, negative regulation of neutrophil chemotaxis, is a critical biological process that restrains neutrophil migration to prevent tissue damage and resolve inflammation. Key molecular players include Rac GTPases, atypical chemokine receptors such as CCRL2, and anti-inflammatory cytokines like IL-10. Dysregulation of this process is implicated in sepsis, cancer, and ocular inflammatory diseases. CRISPR-based models and advanced screening methods provide powerful tools to dissect the underlying mechanisms and identify therapeutic targets.
References
- 1. Dinauer MC. 2003. Regulation of neutrophil function by Rac GTPases.. Curr Opin Hematol 10(1):8-15 PMID: 12483106
- 2. Liu H et al.. 2024. Proteinase 3 depletion attenuates leukemia by promoting myeloid differentiation.. Cell Death Differ 31(6):697-710 PMID: 38589495
- 3. Li JD et al.. 2025. The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective.. BMC Cancer 25(1):1363 PMID: 40846911
- 4. Bruserud Ø et al.. 2023. The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients.. Cells 12(7) PMID: 37048076
- 6. Weiner OD. 2002. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass.. Curr Opin Cell Biol 14(2):196-202 PMID: 11891119
- 7. Mashimo H et al.. 2008. Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis.. Invest Ophthalmol Vis Sci 49(12):5450-7 PMID: 18757518
- 8. Schioppa T et al.. 2020. Molecular Basis for CCRL2 Regulation of Leukocyte Migration.. Front Cell Dev Biol 8:615031 PMID: 33363177
